Autobio Diagnostics Co., Ltd.

SHSE:603658 Stock Report

Market Cap: CN¥26.6b

Autobio Diagnostics Valuation

Is 603658 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 603658 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 603658 (CN¥46.49) is trading above our estimate of fair value (CN¥17.32)

Significantly Below Fair Value: 603658 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 603658?

Key metric: As 603658 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 603658. This is calculated by dividing 603658's market cap by their current earnings.
What is 603658's PE Ratio?
PE Ratio20.9x
EarningsCN¥1.27b
Market CapCN¥26.60b

Price to Earnings Ratio vs Peers

How does 603658's PE Ratio compare to its peers?

The above table shows the PE ratio for 603658 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.8x
600529 Shandong Pharmaceutical GlassLtd
19x18.4%CN¥16.8b
300595 Autek China
26.8x16.8%CN¥17.4b
301371 Harbin Fuerjia Technology
20.1x8.4%CN¥14.6b
688029 Micro-Tech (Nanjing)Ltd
25.1x19.0%CN¥13.8b
603658 Autobio Diagnostics
20.9x20.9%CN¥26.6b

Price-To-Earnings vs Peers: 603658 is good value based on its Price-To-Earnings Ratio (20.9x) compared to the peer average (22.8x).

Price to Earnings Ratio vs Industry

How does 603658's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
603658 20.9xIndustry Avg. 37.3xNo. of Companies16PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 603658 is good value based on its Price-To-Earnings Ratio (20.9x) compared to the CN Medical Equipment industry average (37.3x).

Price to Earnings Ratio vs Fair Ratio

What is 603658's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

603658 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.9x
Fair PE Ratio27.6x

Price-To-Earnings vs Fair Ratio: 603658 is good value based on its Price-To-Earnings Ratio (20.9x) compared to the estimated Fair Price-To-Earnings Ratio (27.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 603658 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥46.49
CN¥58.57
+26.0%
9.7%CN¥66.41CN¥51.80n/a5
Nov ’25CN¥45.38
CN¥58.15
+28.1%
9.1%CN¥66.41CN¥51.80n/a6
Oct ’25CN¥48.16
CN¥56.56
+17.4%
8.2%CN¥66.41CN¥52.80n/a6
Sep ’25CN¥40.84
CN¥56.56
+38.5%
8.2%CN¥66.41CN¥52.80n/a6
Aug ’25CN¥40.89
CN¥65.55
+60.3%
3.7%CN¥70.00CN¥62.54n/a6
Jul ’25CN¥45.65
CN¥65.55
+43.6%
3.7%CN¥70.00CN¥62.54n/a6
Jun ’25CN¥51.29
CN¥65.55
+27.8%
3.7%CN¥70.00CN¥62.54n/a6
May ’25CN¥57.02
CN¥64.39
+12.9%
5.7%CN¥70.00CN¥57.41n/a7
Apr ’25CN¥57.84
CN¥60.64
+4.8%
7.9%CN¥67.80CN¥55.40n/a6
Mar ’25CN¥64.10
CN¥59.49
-7.2%
7.4%CN¥67.80CN¥55.40n/a5
Feb ’25CN¥47.71
CN¥59.49
+24.7%
7.4%CN¥67.80CN¥55.40n/a5
Jan ’25CN¥57.01
CN¥58.43
+2.5%
4.3%CN¥62.50CN¥55.40n/a5
Dec ’24CN¥53.48
CN¥59.14
+10.6%
11.2%CN¥73.00CN¥52.20n/a6
Nov ’24CN¥44.31
CN¥59.14
+33.5%
11.2%CN¥73.00CN¥52.20CN¥45.386
Oct ’24CN¥45.73
CN¥63.18
+38.1%
7.5%CN¥73.00CN¥59.57CN¥48.166
Sep ’24CN¥45.74
CN¥63.18
+38.1%
7.5%CN¥73.00CN¥59.57CN¥40.846
Aug ’24CN¥54.65
CN¥73.54
+34.6%
8.1%CN¥82.11CN¥63.00CN¥40.896
Jul ’24CN¥51.73
CN¥73.54
+42.2%
8.1%CN¥82.11CN¥63.00CN¥45.656
Jun ’24CN¥56.18
CN¥73.54
+30.9%
8.1%CN¥82.11CN¥63.00CN¥51.296
May ’24CN¥57.23
CN¥73.65
+28.7%
8.8%CN¥82.11CN¥63.00CN¥57.025
Apr ’24CN¥60.94
CN¥83.38
+36.8%
11.9%CN¥92.00CN¥64.00CN¥57.845
Mar ’24CN¥65.27
CN¥83.38
+27.7%
11.9%CN¥92.00CN¥64.00CN¥64.105
Feb ’24CN¥66.70
CN¥83.38
+25.0%
11.9%CN¥92.00CN¥64.00CN¥47.715
Jan ’24CN¥61.85
CN¥82.06
+32.7%
9.9%CN¥87.75CN¥66.00CN¥57.015
Dec ’23CN¥60.02
CN¥82.06
+36.7%
9.9%CN¥87.75CN¥66.00CN¥53.485
Nov ’23CN¥66.92
CN¥82.06
+22.6%
9.9%CN¥87.75CN¥66.00CN¥44.315

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.1b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.51

7D

-1.3%

1Y

-30.9%

iRay Technology

CN¥16.1b

Develops, manufactures, and sells flat panel X-ray detectors for use in medical, dental, oncology, veterinary, security, and industrial imaging applications in China and internationally.

688301

CN¥112.93

7D

-5.6%

1Y

-30.5%

Truking Technology

CN¥4.7b

Engages in medical equipment business in China and internationally.

300358

CN¥8.01

7D

3.2%

1Y

-32.9%